• Skip to main content
  • Skip to primary sidebar

Experienced Indiana Law Firm | Trial Lawyers Giving Power to Your Voice for Over 55 Years

CohenMalad, LLP | Trial Lawyers Giving Power to Your Voice for Over 55 Years

CohenMalad is rated highly on Google Reviews by clients.
Toll Free866.446.7478Toll Free317.636.6481
Make a Payment free consult
  • English
  • Español

Search

  • About Us
  • Attorneys
  • Services
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact
  • English
    • Español

Uloric Gout Drug Injuries

Home » Practice Areas » Pharmaceutical Drug And Medical Device Litigation » Uloric Gout Drug Injuries

Attorneys helping people injured after taking Uloric to treat gout

Uloric (febuxostat), a drug manufactured by Takeda Pharmaceuticals, is used to treat gout. Gout is a chronic disease that affects approximately 8.3 million adults in the U.S. It happens when uric acid builds up in the body. Symptoms often appear suddenly. A patient may experience a sudden, severe attack of pain, swelling, redness and tenderness in the joints- often at the base of the big toe, ankle, knee, elbow, wrist, or fingers. Uloric was approved by the U.S. Food and Drug Administration (FDA) in 2009, but recently has received both a Drug Safety Communication and a Black Box Warning after serious injuries and deaths were reported.

FDA Drug Safety Communication for Uloric

On November 15, 2017, the U.S. FDA issued a Drug Safety Communication alert for an increased risk of heart-related deaths associated with Uloric use. This alert was issued after a safety trial involving over 6,000 patients. The primary outcome of that safety trial was a combination of heart-related death, heart attack, stroke, and a condition of inadequate blood supply to the heart requiring urgent surgery.

FDA Black Box Warning for Uloric

In February 2019, the FDA issued another Drug Safety Communication and required the addition of a Black Box Warning for Uloric after concluding an increased risk of death associated with Uloric compared to another gout medication, allopurinol. The Boxed Warning is the most prominent warning the FDA can issue. The FDA stated that Uloric should be used only in patients who have failed or do not tolerate allopurinol. The FDA warned that anyone taking Uloric that experiences chest pain, shortness of breath, rapid or irregular heartbeat, dizziness, numbness or weakness on one side of your body, trouble talking, or severe headache should seek emergency medical attention.

Uloric Injury Lawsuits

Patients and loved ones of patients have filed lawsuits against Uloric maker Takeda Pharmaceuticals after reports of cardiac events and deaths were reported. If you or someone you care about was prescribed Uloric and suffered a heart attack, stroke, or death, contact us. Our attorneys have litigated hundreds of claims against large pharmaceutical companies and medical device manufacturers and can advise you or your legal rights and options.

Primary Sidebar

ASK ABOUT AN INITIAL FREE CONSULTATION TODAY

  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.

CohenMalad, LLP

One Indiana Square Suite 1400
Indianapolis, Indiana 46204
317.636.6481
Toll Free: 866.446.7478
  • twitter logo

Copyright © 2025 CohenMalad, LLP
Disclaimer Privacy Policy

  • About Us
  • Attorneys
  • Services
    ▼
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    ▼
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact
  • English
    ▼
    • Español
Cookies and other technology are used on this website to tailor your user experience and evaluate our marketing strategy. By clicking any link on this site you agree to our privacy policy.
En este sitio web utilizamos cookies y otras tecnologías para personalizar su experiencia de usuario y evaluar nuestra estrategia de marketing. Al hacer clic en cualquier enlace de esta plataforma, usted acepta nuestra política de privacidad.
Agree